SG Americas Securities
PDSB icon

SG Americas Securities’s PDS Biotechnology PDSB Stock Holding History

SG Americas Securities’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9K Buy
+10,367
New +$11K ﹤0.01% 3303
2024
Q1 		– Sell
-10,495
Closed -$52K – 3322
2023
Q4 		$52K Buy
+10,495
New +$52.2K ﹤0.01% 2912
2018
Q2 		– Sell
-805
Closed -$19K – 3494
2018
Q1 		$19K Buy
805
+255
+46% +$68.6K ﹤0.01% 3158
2017
Q4 		$103K Buy
+550
New +$111K ﹤0.01% 2844
2017
Q3 		– Sell
-1,149
Closed -$236K – 3677
2017
Q2 		$236K Buy
+1,149
New +$226K ﹤0.01% 2303

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

SG Americas Securities's PDSB Position: Q2 2026 in Review

SG Americas Securities opened a new position in PDS Biotechnology (PDSB) in Q2 2026: 10,367 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #3303 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in PDSB as recently as Q4 2023.

SG Americas Securities first reported a position in PDSB in Q2 2017 and has held it in 5 quarters since. The position peaked at $236K in Q2 2017. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • SG Americas Securities held 10,367 shares of PDS Biotechnology worth $9K as of Q2 2026.
  • PDS Biotechnology was a new SG Americas Securities position in Q2 2026.
  • PDS Biotechnology made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3303 holding.
  • SG Americas Securities first reported a position in PDS Biotechnology in Q2 2017 and has held it in 5 quarters since.
  • SG Americas Securities's PDS Biotechnology position peaked at $236K in Q2 2017.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.